Research progress in the mechanism of ferroptosis and its role in liver related diseases

doi:10.3969/j.issn.1674-8115.2020.11.015

JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE) ›› 2020, Vol. 40 ›› Issue (11): 1519-1523.doi: 10.3969/j.issn.1674-8115.2020.11.015

• Review • Previous Articles Next Articles

Research progress in the mechanism of ferroptosis and its role in liver related diseases

HE Ming, WEI Qian, ZHANG Ying-ting

Key Laboratory for Cell Differentiation and Apoptosis, Ministry of Education, Department of Pathophysiology, Shanghai Jiao Tong University College of Basic Medical Sciences, Shanghai 200025, China

Online:2020-11-28 Published:2021-01-13
Supported by:
Natural Science Foundation of Shanghai (19ZR1428400); National Natural Science Foundation of China (82070603, 81470841, 92057118); Innovative Research Team of High-Level Local Universities in Shanghai (SSMU-ZDCX20180800); Supported by Youth Science and Technology Innovation Studio of Shanghai Jiao Tong University School of Medicine (JYKCGZS15).

Abstract

Abstract: Ferroptosis is a type of cell death caused by iron-dependent lipid peroxidation. Glutathione peroxidase 4 (GPX4) can prevent ferroptosis by converting lipid peroxides into nontoxic lipid alcohols under normal condition. However, recent studies have shown that ferroptosis in hepatocytes is one of the factors that induce and aggravate various liver diseases such as alcoholic fatty liver disease. Thereby, inducing ferroptosis of cancer cells by inhibiting GPX4 may be a new strategy for the treatment of liver cancer. This article reviews the molecular mechanism of ferroptosis and its role in liver related diseases, in order to provide new research directions and ideas for the treatment of liver diseases.

Key words: ferroptosis, liver disease, lipid peroxidation, glutathione peroxidase 4 (GPX4), liver cancer

CLC Number:

HE Ming, WEI Qian, ZHANG Ying-ting. Research progress in the mechanism of ferroptosis and its role in liver related diseases[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(11): 1519-1523.

[1]	Chao SANG, Dan-dan LIANG, Guo-xiang XIE, Wei JIA, Tian-lu CHEN. Progress in serological noninvasive diagnostic methods for non-alcoholic fatty liver disease [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(1): 112-117.
[2]	GUO Yi-qiong, WU Qiong, WU Ya-ting, GAO Lu-lu, YANG Jian-jun. Effect of Lycium barbarum polysaccharide and aerobic exercise on rats with non-alcoholic fatty liver disease and its mechanism [J]. , 2020, 40(1): 30-.
[3]	ZHU Fan-fan, YANG Li-zhen. Correlation between the levels of serum thyroid hormones and non-alcoholic fatty liver disease in euthyroid type 2 diabetic patients [J]. , 2018, 38(7): 763-.
[4]	JIAN Chao-hui, BAO Yu-qian. Research progress of autophagy in non-alcoholic fatty liver disease [J]. , 2018, 38(6): 690-.
[5]	YING Chen1, LIU Cai-hong2, HU Jia-an2, JIANG Shi-hu3, XU Zhi-hong2, SUN Jing2. Research on level of serum lipid metabolism related hormones in patients of obstructive sleep apnoea hypoxia syndrome combine with non-alcoholic fatty liver disease [J]. , 2018, 38(10): 1203-.
[6]	HOU Ya-nan, XUAN Li-ping, PENG Kui, DU Rui, XU Yu, CHEN Yu-hong, LU Jie-li, BI Yu-fang, XU Min, WANG Wei-qing, NING Guang . Association between mid-upper arm circumference and non-alcoholic fatty liver disease or insulin resistance in middle-aged and elderly Chinese community population#br# [J]. , 2017, 37(9): 1232-.
[7]	HUANG Dong-dong, WO Lu-lu, RUAN Xin, XU Ya-qian, GONG Yi-ming, YANG Lin-xi, LI Xue-chuan, KANG Yue-ning, HE Ming . Construction of a new alcoholic liver disease mouse model [J]. , 2017, 37(7): 906-.
[8]	ZHANG Zhen-zhen, CHEN Zheng, YUAN Qing-qing, SUN Min, NIU Ming-hui, HE Zu-ping. Application of hepatic stem cells and spermatogonial stem cells in treatment of liver disease [J]. , 2016, 36(09): 1351-.
[9]	SUN Wen-wen, RUAN Yu-feng， LIAN Peng, YING Chen, HU Jia-an, XU Zhi-hong, SUN Jing. Effects of obstructive sleep apnoea syndrome on non-alcoholic fatty liver disease [J]. , 2016, 36(05): 707-.
[10]	FENG Jing, DENG Fei, ZHANG Ping, et al. Influence of Venenum Bufonis on proliferation and apoptosis in liver cancer cell HepG2 and relevant mechanisms [J]. , 2016, 36(03): 340-.
[11]	PENG Hai-xia, HOU Ming-yue CHU Yi-min, et al. Inhibitory effects of different isoforms of DLC1 on proliferation and migration of colon cancer cells [J]. , 2016, 36(01): 17-.
[12]	CANG Zhen, ZHU Chao-xia, Jiazireya·Zaiyinati, et al. Isotope labeling experiment of fatty acid oxidation in gastrocnemius of rats with nonalcoholic fatty liver [J]. , 2015, 35(6): 789-.
[13]	XU Li-ping, LI Jia, FANG Lin. Establishment of model of adaboost classifier and evaluation of harmful mutations in non-coding regions of liver cancer cells [J]. , 2015, 35(6): 819-.
[14]	KANG Bing, PENG Chuan, ZUO De-yu, et al. Correlation between secreted frizzled-related protein 5 level and blood lipids in serum of patients with nonalcoholic fatty liver disease [J]. , 2015, 35(5): 694-.
[15]	ZHU Chao-xia, CANG Zhen, Jiazireya·Zaiyinati, et al. Effects of berberine on gut microbiota of rats with non-alcoholic fatty liver disease induced by high-fat diet [J]. , 2015, 35(4): 483-.

Research progress in the mechanism of ferroptosis and its role in liver related diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

TrendMD

References

Related Articles 15

Recommended Articles

Metrics

Comments